Preclinical Cardiovascular Imaging Lab Lead
Initial Therapeutics, Inc.
Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Benefits offered by this job
Job summary
Lilly in Indianapolis invites applications for a Scientific leadership role leading a preclinical imaging laboratory focused on cardiovascular phenotyping. The position requires expertise in rodent echocardiography and ultrasound, and collaboration across MR, SPECT, PET, and CT imaging to support cardiometabolic drug discovery.
You will mentor scientists, drive study design and data interpretation, and advance innovative imaging methods while aligning with Lilly’s pipeline and translational
Qualifications
- Ph.D. in cardiovascular biology, pharmacology, physiology, or related field, or Masters with 8+ years in preclinical imaging.
- 5+ years in rodent echocardiography and ultrasound-based imaging.
- Experience leading laboratory-based scientific work and guiding in vivo studies.
- Experience with additional preclinical imaging modalities preferred.
Responsibilities
- Lead a preclinical imaging laboratory supporting cardiovascular and renal drug discovery programs.
- Provide imaging expertise across MR, SPECT, PET and CT to support studies.
- Provide scientific and operational leadership for design, execution, and interpretation of imaging studies.
- Develop and validate imaging methods and imaging-based delivery of therapeutics.
- Collaborate with biology, pharmacology, and translational teams; communicate findings clearly.
Skills
Education
Tools
Job description
Lilly in Indianapolis invites applications for a Scientific leadership role leading a preclinical imaging laboratory focused on cardiovascular phenotyping. The position requires expertise in rodent echocardiography and ultrasound, and collaboration across MR, SPECT, PET, and CT imaging to support cardiometabolic drug discovery.
You will mentor scientists, drive study design and data interpretation, and advance innovative imaging methods while aligning with Lilly’s pipeline and translational
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
